My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 321

    1.

    Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.

    Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A.

    Ann Intern Med. 2000 Jul 18;133(2):111-22.PMID: 10896637 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.

    Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE Jr, Clasey JL, Heymsfield SB, Bach MA, Vance ML, Thorner MO.

    Ann Intern Med. 2008 Nov 4;149(9):601-11.PMID: 18981485 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.

    Sesmilo G, Fairfield WP, Katznelson L, Pulaski K, Freda PU, Bonert V, Dimaraki E, Stavrou S, Vance ML, Hayden D, Klibanski A.

    J Clin Endocrinol Metab. 2002 Apr;87(4):1692-9.PMID: 11932303 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study.

    Beauregard C, Utz AL, Schaub AE, Nachtigall L, Biller BM, Miller KK, Klibanski A.

    J Clin Endocrinol Metab. 2008 Jun;93(6):2063-71. Epub 2008 Apr 1.PMID: 18381581 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial.

    Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A.

    Ann Intern Med. 1996 Dec 1;125(11):883-90.PMID: 8967668 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.

    Herrmann BL, Berg C, Vogel E, Nowak T, Renzing-Koehler K, Mann K, Saller B.

    Horm Metab Res. 2004 Jan;36(1):54-61.PMID: 14983408 [PubMed - indexed for MEDLINE]Related articles

    7.

    The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

    Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D.

    J Clin Endocrinol Metab. 1998 Jan;83(1):107-16.PMID: 9435425 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.

    Florakis D, Hung V, Kaltsas G, Coyte D, Jenkins PJ, Chew SL, Grossman AB, Besser GM, Monson JP.

    Clin Endocrinol (Oxf). 2000 Oct;53(4):453-9.PMID: 11012570 [PubMed - indexed for MEDLINE]Related articles

    9.

    Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study.

    Christ ER, Cummings MH, Lumb PJ, Crook MA, Sönksen PH, Russell-Jones DL.

    Clin Endocrinol (Oxf). 1999 Aug;51(2):173-9.PMID: 10468987 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial.

    Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A.

    J Clin Endocrinol Metab. 2001 Apr;86(4):1518-24.PMID: 11297577 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.

    Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A.

    J Clin Endocrinol Metab. 2000 Oct;85(10):3720-5.PMID: 11061530 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.

    Lo J, You SM, Canavan B, Liebau J, Beltrani G, Koutkia P, Hemphill L, Lee H, Grinspoon S.

    JAMA. 2008 Aug 6;300(5):509-19.PMID: 18677023 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.

    Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG.

    Growth Horm IGF Res. 2008 Aug;18(4):318-24. Epub 2008 Mar 4.PMID: 18289903 [PubMed - indexed for MEDLINE]Related articles

    14.

    Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).

    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.

    Growth Horm IGF Res. 2008 Aug;18(4):307-17. Epub 2008 Feb 20.PMID: 18282776 [PubMed - indexed for MEDLINE]Related articles

    15.

    Gender difference in the response of growth hormone (GH)-deficient adults to GH therapy.

    Hayes FJ, Fiad TM, McKenna TJ.

    Metabolism. 1999 Mar;48(3):308-13.PMID: 10094105 [PubMed - indexed for MEDLINE]Related articles

    16.

    Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.

    Yuen KC, Frystyk J, White DK, Twickler TB, Koppeschaar HP, Harris PE, Fryklund L, Murgatroyd PR, Dunger DB.

    Clin Endocrinol (Oxf). 2005 Oct;63(4):428-36. Erratum in: Clin Endocrinol (Oxf). 2005 Nov;63(5):599. PMID: 16181235 [PubMed - indexed for MEDLINE]Related articles

    17.

    Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials.

    Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P; Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials.

    J Clin Endocrinol Metab. 2004 May;89(5):2192-9.PMID: 15126541 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The favourable effects of growth hormone (GH) substitution on hypercholesterolaemia in GH-deficient adults are not associated with concomitant reductions in adiposity. A 12 month placebo-controlled study.

    Vahl N, Jørgensen JO, Hansen TB, Klausen IB, Jurik AG, Hagen C, Christiansen JS.

    Int J Obes Relat Metab Disord. 1998 Jun;22(6):529-36.PMID: 9665673 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial.

    Binder EF, Williams DB, Schechtman KB, Jeffe DB, Kohrt WM.

    Ann Intern Med. 2001 May 1;134(9 Pt 1):754-60.PMID: 11329233 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein(a) in growth hormone-deficient adults.

    Webster JM, Stewart M, al-Maskari M, Osman I, Kendall-Taylor P, Mitcheson J, Laker MF.

    Atherosclerosis. 1997 Aug;133(1):115-21.PMID: 9258415 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity